(Circulation. 1997;95:753.)
© 1997 American Heart Association, Inc.
Articles |
the Cardiology Service, Fitzsimons Army Medical Center, Aurora, Colo.
Correspondence to Talley F. Culclasure, MD, Cardiology Service, Department of Medicine, Fitzsimons Army Medical Center, Aurora, CO 80045-5001.
| Introduction |
|---|
|
|
|---|
The patient's surgical risk for removal of the clot was increased by his prior surgery and elevated pulmonary pressures. Because of this, he was treated with a peripheral intravenous infusion of 100 mg of tissue plasminogen activator over 2 hours without a bolus. Repeat transthoracic echocardiography 4 hours after and transesophageal echocardiography 24 hours after initiation of thrombolytic therapy revealed no evidence of the thrombus and a dramatic improvement in right ventricular chamber size and pulmonary pressures. There was no evidence of systemic embolization, and the patient was discharged several days later on oral anticoagulation medication.
|
| Footnotes |
|---|
Circulation encourages readers to submit cardiovascular images to Dr Hugh A. McAllister, Jr, St Luke's Episcopal Hospital and Texas Heart Institute, 6720 Bertner, MC 4-265, Houston, TX 77030.
This article has been cited by other articles:
![]() |
V. Aboyans, P. Lacroix, E. Ostyn, E. Cornu, and M. Laskar Diagnosis and management of entrapped embolus through a patent foramen ovale Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 624 - 628. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |